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Introduction: Pediatric autoimmune neuropsychiatric disorders associated with strepto-
coccal infection (PANDAS) remains a controversial diagnosis and it is unclear how frequently
it is encountered in clinical practice. Our study aimed to determine how many children with
acute-onset tics and/or Obsessive–Compulsive Disorder (OCD) met criteria for PANDAS.
Materials and methods: A retrospective review was performed on 39 children who
presented to a movement disorders clinic with acute-onset tics or OCD from 2005 to
2012.
Results: Out of 284 patients seen over the course of 7 years, only 39 had acute-onset
tics and/or OCD symptoms. None of the 39 children who presented to us acutely met
full criteria for PANDAS. Thirty-eight percent had no association between their symptoms
and group A beta-hemolytic streptococcal infection, while 54% had prior inconclusive lab-
oratory testing done and no exacerbations during the course of the study. Only 8% of
patients had an acute exacerbation after their initial visit; however, testing for GAHBS in
these patients was negative
Discussion: Our results support the notion that PANDAS, if it exists, is an exceedingly
rare diagnosis encountered in a pediatric movement disorder clinic. While none of our
patients met criteria for PANDAS, two with acute-onset OCD would have met criteria for
pediatric acute-onset neuropsychiatric syndrome (PANS) indicating that PANS may be a
more appropriate diagnosis.
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INTRODUCTION
The diagnosis of pediatric autoimmune neuropsychiatric dis-
orders associated with streptococcal infection (PANDAS) has
been controversial since its initial description. Researchers orig-
inally described a subgroup of patients who developed obsessive–
compulsive disorder (OCD)-like behaviors and/or tics following
a group A beta-hemolytic Streptococcal (GABHS) infection (1).
The current diagnostic criteria for PANDAS are as follows: (1) the
presence of OCD or tic disorder; (2) prepubertal age at onset (usu-
ally ages 3–12 years); (3) abrupt symptom onset and/or episodic
course of symptom severity; (4) temporal association between
symptom exacerbations and GABHS infection; and (5) associa-
tion with neurologic abnormalities during symptom exacerbation
(2). Currently, the exact pathophysiology of PANDAS is not fully
understood. It is postulated that in these patients, a GABHS infec-
tion results in the formation of anti-streptococcal antibodies that
attack specific areas of the brain creating an autoimmune disease
similar to Sydenham’s chorea (3).
There have been criticisms of the PANDAS hypothesis, ques-
tioning whether PANDAS is in fact a unique entity, or is
simply a coincidental association between an extremely com-
mon bacterial infection and the concurrent but unrelated emer-
gence of a neuropsychiatric disorder (4–6). In light of this
controversy, our study aimed to discern how many patients who
presented to a pediatric movement disorders practice with acute-
onset tics, Tourette’s syndrome, or OCD met the criteria for
PANDAS.
MATERIALS AND METHODS
This study was conducted at the Movement Disorders Clinic at the
Children’s Hospital of Eastern Ontario (CHEO) in Ottawa, ON,
Canada, a hospital with over 300,000 children ages 0–19 years in
its catchment area. Most patients with new onset tics in our catch-
ment area are referred to this clinic; additionally, the director (AD)
has made other services, such as general pediatrics and psychiatry,
aware of the desire to assess patients with possible PANDAS. As
such, patients with tic disorders or OCD who are seen in other
clinics are often referred to the Movement Disorders Clinic if the
diagnosis of PANDAS is entertained. Acute symptom onset has
been deemed the most useful in identifying children in the PAN-
DAS group (5). As such, patients with acute-onset of symptoms
were followed in our clinic over time. For our purposes, acute
onset was defined as the parents or child being able to identify the
day or week the symptoms began.
Many patients referred to our clinic had throat swabs, anti-
streptolysin O titers (ASOT), or anti-DNAse B performed prior to
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Table 1 | Summary throat swab findings, serology results, and final diagnosis of patients who developed acute tic exacerbations after initial
visit.
Patient Exacerbations Throat swab ASOT (IU/mL) Anti-DNase B
(unit/mL)
Final diagnosis
Patient A – first
assessed on October
2011
Exacerbations in
February 2012,
December 2012, May
2013
• Negative, February
2012
• Negative, December
2012
• Negative, May 2013
• 51 (low) February
2012
• 181 (high)
December 2012
• 105 (low) May 2013
Not done Tourette’s syndrome
and ADHD
Patient B – first
assessed on June
2007
Exacerbation April
2009
• Negative April 2009 • 783 (high) April 6th
2009
• 387 (high) April 22nd
2009
• 240 (high) April 22nd
2009
•Tourette’s syndrome
Patient C – first
assessed on October
2008
Exacerbation in
October 2010
• Negative October
2010
• 47 (low) October
2010
• 85 (low) October
2010
•Tic disorder NOS
and ADHD
them being seen in our clinic. However, given the fact these that
tests were often performed outside of our institution by a variety
of practitioners, it was difficult to accurately correlate the timing of
these tests with symptom exacerbation. As such, we felt that PAN-
DAS could only be accurately diagnosed by following patients in
our clinic after their initial appointment.
For the purposes of our study, “time zero” was the date when
the patients initially presented to our clinic. Patients were then
followed over time – families were asked to phone the clinic imme-
diately if the patient had an exacerbation in symptoms; in these
cases, a throat swab and either an ASOT or anti-DNAse B would be
done immediately (within 7 days), and convalescent titers would
be done 2–6 weeks later. A diagnosis of PANDAS would be made
if, during the time of follow-up, a patient had one or more exac-
erbations in symptomatology associated with an acute GABHS
infection (defined as a positive throat swab and a positive ASOT
and/or anti-DNAse B acutely, with normal or decreasing serologic
titers in the convalescent phase).
We retrospectively reviewed this data for patients who pre-
sented between 2005 and 2012 including: demographic informa-
tion, date of acute onset of symptoms, association with GABHS
infection including lab results for throat swabs and ASOT and/or
anti-DNAse B levels, clinical symptoms, length of follow-up, and
number of acute exacerbations since first neurology consultation
and the patient’s final diagnosis. Patients were excluded if their
final diagnosis was rheumatic fever/Sydenham’s chorea, or if the
acute emergence of their tics coincided with the initiation of a
stimulant medication.
This study received ethical approval from the Children’s
Hospital of Eastern Ontario Research Ethics Board.
RESULTS
Out of 284 children (72% male, 28% female) who presented to
our clinic with tics, Tourette’s syndrome, or OCD, 39 (14%) had
an acute onset of symptoms and were followed in our clinic over
time. The mean length of follow-up was 2 years, ranging from 0 to
5 years. Eleven patients (28%) were lost to follow-up. Thirty-one
(79%) patients had tics, 3 (8%) had OCD, and 5 (13%) had tics
and OCD.
Prior to being seen at our clinic, 24 patients had prior laboratory
investigations done (10 had ASOT, throat swab and an anti-DNse
B, 8 had throat swabs only, 3 had ASOT and an anti-DNAse B, 2
had ASOT and a throat swab, and 1 had ASOT only) in an attempt
to detect a GABHS infection, while 15 patients had no laboratory
investigations done indicating that PANDAS was not considered
as a possible diagnosis for their symptomatology. Out of those 24
patients, 17 had at least one positive investigation, and 7 had nor-
mal results. However all of these investigations were undertaken by
other providers (and consequently it was difficult to establish the
timing of the test with regards to the exacerbation) or they were
not taken during an acute exacerbation at all and thus a diagnosis
of PANDAS could not be made. Upon following each patient after
their initial consultation in our clinic, only three patients reported
acute exacerbations of tics and/or OCD (see Table 1 below). These
patients had an ASOT, anti-DNAse B, and throat swab done within
1 week of the patient informing our clinic of an exacerbation. As
is evident from the results in Table 1, none of these patients had
positive throat swabs or antibody titers needed to make a PANDAS
diagnosis. The final diagnoses of these patients were: 14 (35.9%)
with transient tics disorder of childhood, 10 (25.6%) with tic dis-
order not otherwise specified, 9 (23.1%) with Tourette’s syndrome,
4 (10.3%) with OCD, and 2 (5.1%) with chronic motor tic.
DISCUSSION
Very few patients in our study with an initial acute presentation had
a subsequent acute relapse. Those who did have acute exacerba-
tions did not have evidence for a co-existing GABHS infection; as
such, no patients met criteria for PANDAS. Thus, while our study
cannot “refute” the existence of PANDAS, it is reasonable to state
that it would have to be considered an extremely uncommon diag-
nosis, given the fact that no patients were diagnosed conclusively
during the 7 years of the study.
Our results mirror those by Gabbay et al., who found that
when strict diagnostic criteria were applied, most children (19/31
Frontiers in Pediatrics | Neuropediatrics September 2014 | Volume 2 | Article 104 | 2
Kilbertus et al. Retrospective PANDAS cases
or 61.3%) who initially received PANDAS diagnoses in the
community did not meet the full criteria for PANDAS (7).
In light of the controversy surrounding PANDAS, researchers
have discussed the possibility of redefining PANDAS into a broader
syndrome termed childhood acute neuropsychiatric symptoms
(CANS) (4) or pediatric acute-onset neuropsychiatric syndrome
(PANS) (8). A diagnosis of CANS requires only the acute onset of
neuropsychiatric symptoms, followed by a thorough history and
physical examination and an active search for a specific etiology
(4). PANS, however, requires abrupt onset of OCD or severely
restricted food intake; concurrent presence of at least two neu-
ropsychiatric symptom with similarly severe and acute onset (i.e.,
anxiety, emotional lability, aggression, sensory or motor abnor-
malities, somatic signs and symptoms); and symptoms that are
not better explained by a known neurological or medical disorder
(8). Both CANS and PANS are much broader than PANDAS and
include not only disorders potentially associated with a preceding
infection, but also acute-onset neuropsychiatric disorders without
an obvious precipitant (8). While none of our patients met criteria
for PANDAS, two with acute-onset OCD would have met criteria
for PANS, indicating that there may be a stronger basis for the
existence of PANS as an entity or, at the very least, that PANS is
more common than PANDAS.
There are several limitations, which need to be taken into
account when interpreting our results. There is the possibility that
certain PANDAS cases were referred to other physicians in or out-
side of our institution and were therefore missed; however, we did
make it known to other providers that we were interested in assess-
ing patients with possible PANDAS. Additionally, 11 patients were
lost to follow-up thus we are unable to accurately determine in
those patients whether or not they had acute exacerbations, which
would fulfill the PANDAS criteria.
Another limitation is that we did not assess patients during
their first acute presentation. More often, these patients were seen
initially by their primary care practitioner or by emergency room
clinicians. Thus, many patients had laboratory tests performed
prior to them being seen in our clinic. Since we were not able to
accurately correlate the timing of the tests with the acute clinical
presentation, some genuine GABHS-associated tic or OCD exacer-
bations that would have met criteria for PANDAS may have been
missed. However, given that PANDAS patients typically have a
relapsing course (2), one would assume that most of these patients
should have gone on to have subsequent exacerbations of their
symptoms associated with GABHS, which we did not see in our
study population.
It is clear that further prospective studies are needed in
order to elucidate whether or not PANDAS is a true clinical
entity; our results suggest that in a tertiary movement disorders
clinic CANS or PANS would be better diagnostic categories for
pediatric patients who present with acute-onset neuropsychiatric
symptoms.
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